Atea Pharmaceuticals Cash Flow Statement 2018-2024 | AVIR

Fifteen years of historical annual cash flow statements for Atea Pharmaceuticals (AVIR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-135.96$-115.91$121$-10.95$-14.03$-9.06
$-15.03$-5.21$0.03$0.02$0.02$0.02
$49.43$46.72$39.62$7.46$0.62$0.41
$34.40$41.51$39.65$7.48$0.64$0.43
$0$0$0$-5.82$0$0
$0$0$0$0$0$0
$1.70$-1.98$10.29$-0.49$0.16$-0.09
$1.80$-6.98$-302.01$294$-0.04$0.09
$16.16$-46.59$-247.85$300$0.56$0.73
$-85.40$-120.98$-87.01$297$-12.83$-7.91
$0$-1.94$0.00$-0.03$0.00$-0.01
$0$0$0$0$0$0
$0$0$0$0$0$0
$40.30$-453.47$0$0$0$0
$0$0$0$0$0$0
$40.30$-453.47$0$0$0$0
$0$0$0$0$0$0
$40.30$-455.41$0.00$-0.03$0.00$-0.01
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.26$0.37$1.47$318$0$0.12
$0.26$0.37$1.47$532$0$27.48
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.26$0.37$1.47$532$0$27.48
$-44.84$-576.02$-85.54$828$-12.83$19.56
$49.43$46.72$39.62$7.46$0.62$0.41
$0$0$0$0$0$0